Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome ...

Confirmation Received from MHLW That QRX003 Qualifies for Both Orphan Drug Designation and Fast Track Regulatory Review Status Quoin Initiating the Establishment of a Japanese Subsidiary to Facilitate ...

Confirmation Received from MHLW That QRX003 Qualifies for Both Orphan Drug Designation and Fast Track Regulatory Review ...

The distinct foot odor that comes with the skin disorder Nagashima-type palmoplantar keratosis (NPPK) is caused by the overgrowth of a specific bacterial strain, according to a study published in the ...

The distinct foot odor that comes with the skin disorder Nagashima-type palmoplantar keratosis (NPPK) is caused by the overgrowth of a specific bacterial strain. The Kobe University result also shows ...

Bator M, Usnarska-Zubkiewicz L, Dębski J, et al. Paraneoplastic palmoplantar keratoderma secondary to multiple myeloma. Pol Arch Intern Med. 2025; 135: 17162. doi:10 ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Quoin Pharmaceuticals ( (QNRX)) has ...

Abstract: High axial resolution in Optical Coherence Tomography (OCT) images is essential for accurately diagnosing skin conditions like psoriasis and keratoderma, where clear boundary delineation can ...

Patients with Nagashima-type palmoplantar keratoderma (NPPK) experience progressive, painful hyperkeratosis and fissuring of palms and soles that limits daily activities Due to the incomplete ...

NESS ZIONA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Kamari Pharma, a privately-held clinical stage biotechnology company developing first and best-in-class treatments for rare and severe genetic ...